Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

$24.99

Analysis of Liquidity Ratios

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Liquidity Ratios (Summary)

UnitedHealth Group Inc., liquidity ratios

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Current ratio
Quick ratio
Cash ratio

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The liquidity position, as indicated by the observed ratios, demonstrates a generally stable but subtly shifting trend over the five-year period. While the current and quick ratios exhibit relative consistency, the cash ratio reveals a noticeable decline. Overall, the company maintains a short-term asset base that covers its immediate liabilities, but the composition of those assets is evolving.

Current Ratio
The current ratio remained relatively flat between 2021 and 2025, fluctuating between 0.77 and 0.83. It began at 0.79 in 2021, decreased slightly to 0.77 in 2022, recovered to 0.79 in 2023, increased to 0.83 in 2024, and then returned to 0.79 in 2025. This suggests a consistent ability to cover short-term liabilities with short-term assets, with minimal variation over the period.
Quick Ratio
Similar to the current ratio, the quick ratio exhibited a stable pattern. Starting at 0.72 in 2021, it decreased to 0.70 in 2022, then increased to 0.73 in 2023 and 0.75 in 2024 before declining to 0.70 in 2025. The quick ratio’s consistency indicates a reliable capacity to meet short-term obligations with the most liquid assets, excluding inventory.
Cash Ratio
A clear downward trend is observed in the cash ratio. Beginning at 0.36 in both 2021 and 2022, it decreased to 0.34 in 2023, then to 0.28 in 2024, and further to 0.24 in 2025. This indicates a decreasing proportion of current assets held as cash, potentially suggesting a shift towards other, less liquid, short-term investments or increased deployment of cash into operations. While still representing a portion of immediate liabilities, the company’s reliance on cash to cover these obligations is diminishing.

In summary, the company demonstrates a consistent short-term solvency position based on the current and quick ratios. However, the declining cash ratio warrants further investigation to understand the underlying reasons for the shift in asset allocation and its potential implications for short-term financial flexibility.



Current Ratio

UnitedHealth Group Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Current assets
Current liabilities
Liquidity Ratio
Current ratio1
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Current Ratio, Sector
Health Care Equipment & Services
Current Ratio, Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =

2 Click competitor name to see calculations.


The current ratio exhibits a relatively stable pattern over the five-year period, fluctuating within a narrow range. While there are some year-to-year changes, no strong upward or downward trend is apparent.

Current Ratio Trend
The current ratio began at 0.79 in 2021. It decreased slightly to 0.77 in 2022 before recovering to 0.79 in 2023. A modest increase was observed in 2024, reaching 0.83, but it subsequently declined to 0.79 in 2025, returning to the level observed in 2021 and 2023.

The observed fluctuations suggest a consistent, but not dramatically changing, ability to cover short-term liabilities with short-term assets. The ratio consistently remains below 1, indicating that current liabilities exceed current assets in each year examined. This suggests a reliance on asset conversion or financing to meet immediate obligations.

Relationship to Underlying Components
Current assets increased steadily throughout the period, growing from US$61,758 million in 2021 to US$90,582 million in 2025. However, current liabilities experienced a more substantial increase, rising from US$78,292 million in 2021 to US$114,897 million in 2025. The faster growth of liabilities relative to assets explains the limited movement in the current ratio.

The slight improvement in the current ratio in 2024 was likely driven by a slower growth rate in current liabilities compared to current assets. However, this improvement was not sustained, as the ratio reverted to its previous level in 2025. Overall, the current ratio demonstrates a consistent, though somewhat constrained, liquidity position.



Quick Ratio

UnitedHealth Group Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Cash and cash equivalents
Short-term investments
Accounts receivable, net of allowances
Other current receivables, net of allowances
Assets under management
Total quick assets
 
Current liabilities
Liquidity Ratio
Quick ratio1
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Quick Ratio, Sector
Health Care Equipment & Services
Quick Ratio, Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =

2 Click competitor name to see calculations.


The quick ratio exhibited a fluctuating pattern over the five-year period. While generally remaining within a narrow range, subtle shifts are observable. Total quick assets demonstrated consistent growth throughout the period, while current liabilities increased at a faster rate initially, then moderated.

Quick Ratio Trend
The quick ratio began at 0.72 in 2021, decreased slightly to 0.70 in 2022, and then recovered to 0.73 in 2023. A further increase to 0.75 was noted in 2024, followed by a decline to 0.70 in 2025. This suggests a moderate level of short-term liquidity that experienced some volatility.
Asset and Liability Dynamics
Total quick assets increased from US$56,438 million in 2021 to US$80,836 million in 2025, representing a substantial overall increase. However, current liabilities grew from US$78,292 million in 2021 to US$114,897 million in 2025. The initial faster growth of liabilities compared to assets contributed to the dip in the quick ratio in 2022. The subsequent moderation in liability growth allowed the quick ratio to improve in 2023 and 2024, but renewed growth in liabilities in 2025 led to a decrease.

The observed fluctuations in the quick ratio, despite the overall growth in quick assets, indicate that the company’s ability to meet its immediate obligations with its most liquid assets is sensitive to changes in current liabilities. The ratio remained below one throughout the period, suggesting the company does not have a dollar of quick assets for every dollar of current liabilities.



Cash Ratio

UnitedHealth Group Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in millions)
Cash and cash equivalents
Short-term investments
Assets under management
Total cash assets
 
Current liabilities
Liquidity Ratio
Cash ratio1
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
Cash Ratio, Sector
Health Care Equipment & Services
Cash Ratio, Industry
Health Care

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =

2 Click competitor name to see calculations.


The cash ratio exhibited a consistent, albeit gradual, decline over the five-year period examined. While total cash assets increased initially, the growth in current liabilities outpaced this increase, resulting in a decreasing ability to cover short-term obligations with only cash and cash equivalents.

Cash Ratio Trend
The cash ratio remained relatively stable at 0.36 in both 2021 and 2022. A slight decrease to 0.34 was observed in 2023. This decline accelerated in 2024, with the ratio falling to 0.28, and continued into 2025, reaching 0.24. This represents a cumulative decrease of 33.3% from 2021 to 2025.
Cash Assets
Total cash assets increased from US$28,356 million in 2021 to US$33,383 million in 2023, representing a peak in the observed period. However, cash assets then decreased in subsequent years, falling to US$29,113 million in 2024 and further to US$28,121 million in 2025. This suggests a potential shift in asset allocation or increased investment in other areas.
Current Liabilities
Current liabilities demonstrated a consistent upward trend throughout the period. From US$78,292 million in 2021, they increased to US$89,237 million in 2022, US$99,054 million in 2023, US$103,769 million in 2024, and reached US$114,897 million in 2025. This continuous growth in short-term obligations is the primary driver of the declining cash ratio.

The observed trend suggests a growing reliance on sources other than immediately available cash to meet short-term obligations. While not necessarily indicative of immediate financial distress, the decreasing cash ratio warrants further investigation into the composition of current liabilities and the company’s overall liquidity management strategy.